Germany's Brainlab Puts IPO on Hold
16 Articles
16 Articles
Within just over a week, two companies have cancelled their move to Frankfurt in the short term. Why do companies in this country no longer trust in the stock exchange? By Bianca von der Au.
Founded in 1989, the medical technology company Brainlab is no longer a start-up, but an established company in its industry. However, the planned move to the stock exchange does not go as planned.
Founded in 1989, the medical technology company Brainlab is no longer a start-up, but an established company in its industry. However, the planned move to the stock exchange does not go as planned.
So far, only the electrical engineering specialist Pfisterer and the software company Innoscripta have made the leap to the Frankfurt Stock Exchange this year. Actually, Brainlab wants to pursue a hope for new emissions.
Despite the withdrawal of Autodoc, the IPO of the Munich-based Medtech company will most likely succeed next week. It would be the largest IPO this year in Germany. The board of directors is a former head of Siemens.
Which investments are currently in the showcase? What moves the markets? Which companies and heads make prices and what need for action results for your depot? In our market compass, we deal today with the following topics among others: BMW benefits from analyst commentary +++ Brainlab-IPO canceled +++ Renault with billion loss.
Coverage Details
Bias Distribution
- 60% of the sources are Center
To view factuality data please Upgrade to Premium